The purpose of the study was to screen the eŠects of formulation factors on the in vitro release proˆle of diclofenac sodium from matrix pellets compressed into multiple unit pellet system (MUPS) tablets using design of experiment (DOE). Extended release of diclofenac sodium was accomplished using Carbopol71G as matrix substance. According to Fractional Factorial Design FFD 2 3 1 four formulations of diclofenac sodium MUPS matrix tablets were prepared. The process of direct pelletization and subsequently compression of the pellets into tablets was applied in order to investigate a diŠerent approach in formulation of matrix systems and to achieve a better control of the process factors over the principal response -the release of the drug. The investigated factors were X 1 -the percentage of polymer Carbopol 71G, X 2 -crushing strength of the tablet and X 3 -diŠerent batches of the diclofenac sodium. In vitro dissolution time proles at 6 diŠerent sampling times were chosen as responses. Results of drug release studies indicated that drug release rates vary between diŠerent formulations, with a range of 1 to 8 h to complete dissolution. The most important impact on the drug release had factor X 1 -the percentage of polymer Carbopol71G. The polymer percentage is suggested as release regulator for diclofenac sodium release from MUPS matrix tablets. All other investigated factors had no signiˆcant in‰uence on the release proˆle of diclofenac sodium.
INTRODUCTION
Hydrophilic gel-forming matrix tablets are widely used as oral extended-release dosage forms. 1, 2) The overall rate of drug release is regulated by the viscosity and thickness of the gel layer formed by the matrix tablet. Water penetrates the polymer matrix leading to polymer's swelling by decreasing the glass transition temperature of polymer to the experimental temperature thus leading to transformation of glassy polymer into a rubbery phase. 3) In vitro release of water-soluble drugs from hydrophilic matrix systems is mainly controlled by diŠusion out of the gel layer, whereas release for poorly soluble drugs is usually controlled by polymer relaxation-dissolution. Concentration of a matrix forming polymer in the matrix tablet's formulation is crucial for adequate drug release mechanism and also for other tablet's characteristics (mechanical properties, drug dissolution rate, disintegration time, water uptake, etc.). 4) Carbopol is a cross-linked polymer of acrylic acid with a high molecular weight that forms a hydro gel in aqueous solutions depending on the degree of hydration of the carboxyl group in the molecule. Carbopol has many advantages as a candidate for an extendedrelease tablet matrix, e.g., a good gel-forming ability and mucoadhesive property. 5, 6) Although there are few studies for the production of granules containing carbomer by extrusion-spheronization method, 7) there is no literature data concerning formulation of multiple unit pellet system -MUPS/Carbopol units, intended for drug's extended release. All types of carbomer induces serious problems regarding formulation processes owing to their swelling and gelling properties in water, the reduction of tack is necessary for a successful formulation development. Formulation changes, with the presence of anti-tack action of electrolytes and excipients may induce diŠerent release proˆle of drug from matrix pellets compressed into MUPS tablets. 8) MUPS are tablets whose sub-units (pellets) are compacted after embedding in appropriate excipients /cushioning agents. MUPS are reservoair type of devices with or without coating. The active pharmaceutical ingredient may also be blended or granulated with polymers to provide additional level of control. One way to design oral modiˆed release systems is to coat spherical pellets with a polymer that regulates their drug release rate. Such pellets can be compacted into multiple unit tablets which are normally intended to disintegrate into discrete pellets in the gastrointestinal tract and the drug should subsequently be released in a controlled manner from the individual pellets. One challenge in the production of such tablets is maintaining the desired drug release after compaction, as the application of compaction pressure can lead to structural changes in theˆlm coating and, consequently, altered drug release. 9) The compression induced changes in the structure of â lm coating may depend on formulation factors, such as the type of coating, the properties and the structure of the pellets and the incorporated excipients. In this study, diŠerent approach of design oral modiˆed release systems is applied, where uncoated pellets were compessed into MUPS tablets and in‰uence of diŠerent formulation factors on drug release mechanism was investigated.
Compression behaviour of uncoated pellets can provide basis for the formulation of multiple unit tablets from barier coated pellets without damaging their coating. Pellets have been found to react diŠer-ently to compaction and consolidation than powders of the same material. The powders examined were found to compact by plastic deformation and produced strong compacts, while the pellets exhibited elastic deformation and brittle fragmentation resulting in compacts of lower tensile strength. This can be explained by the fact that pellets which are large and spherical in shape as compared to the small irregular powder particles they are composed of, have a low surface to volume ratio which might result in decreasing area of contact between the particles as they consilidate. The size of the pellets can also have the bearing on their compression behaviour. Small pellets have been found to be less aŠected than larger ones by the compaction process. Some were able to correlate this directly to the individual bead strength i.e., the smaller beads wet signiˆcantly stronger, relative to their size, than the larger ones. Some, found the deformation of the individual pellets to be correlated to their size, i.e., larger pellets were redily deformed. 10, 11) The purpose of the study was to screen the eŠects of formulation factors on the in vitro release proˆle of diclofenac sodium from matrix pellets compressed into MUPS tablets using design of experiment (DOE). Finally release regulation using Carbopol is discussed and optimal formulations are suggested.
Diclofenac sodium was selected as a model drug. It is generally known that diclofenac sodium migrates into the blood within 30 min and reaches the maximum concentration in blood within 2 h after oral administration and the blood concentration half life is as short as 1.3 h. Since diclofenac sodium is quickly absorbed in and excreted from blood, it is di‹cult to maintain in the therapeutic level for a long time. For this reason currently comercially available diclofenac sodium tablets must be taken three times a day. Oral administration of diclofenac sodium often induces various side eŠects including gastroenteritis. The utility of diclofenac sodium which is a non-steroidal antiin‰amatory drug is highly appreciated because of its strong anti-in‰amatory and analgesic actions. Therefore there is a strong need for the development of a long acting diclofenac sodium preparation which is capable of exhibiting the eŠect in a most safe and e‹ciency manner over an extended period of time. 12) 
MATERIALS AND METHODS

Materials
Diclofenac sodium batch A (manufacturer A, Switzerland), Diclofenac sodium batch B (manufacturer B, Switzerland), Carbopol 71G (Lubrizol, USA), AvicelPH 101 (FMC, USA), Magnesium stearate (Sandoz Pharma AG, Switzerland) and Aerosil(Evonik, Germany).
Powder Characterization Particle size distribution Two diŠerent batches of diclofenac sodium were characterized.The average particle size was determined by Malvern, Mastersizer X, (Worcestershire, UK). The measurements were carried out at least 3 times for each sample. The average and the median particle size of all samples were measured using MS 64-Dry powder feeder (Model MSX 64, Malvern Instruments, Worcestershire, UK).
For examination of pellets particle size distribution the following instrument settings had been done: The federate was set to level 5 and the air pressure was set between 1 3 bars, the number of sweeps was set to 30 000 in a time frame of 60 s; the active beam length was set to 10 mm with a range lens of 1000 mm; a minimum obscuration value of 1 10％ was obtained in all measurements. With the software (Malvern) the particle size distribution of the samples including mean and medium particle size could be calculated from the raw data. The function``polydispers'' was activated. The average particle sizes of all samples mentioned above were ＞50 mm, therefore, thè`F rauenhofer'' model was chosen (according to the recommendation of Malvern). For the API diclofenac sodium which was in powdery form, diŠerent settings had to be done because it was not possible to determine the particle size distribution with the dry powder feeder without generating artefacts: Huge powder clusters appeared (＞1000 mm), that could not been separated by increasing the air pressure or by changing the feedrate. Therefore, the particle size distribution had to be determined in a liquid with a MS-1-Small Volume presentation sample unit (Model: MS 519, Malvern Instruments, Worcestershire, UK). For the diŠerent samples, diŠerent liquids need to be chosen, in order not to dissolve or swell the sample. The particle size of diclofenac sodium was determined in Aceton. The following settings has been done: The number of sweeps was set to 2000 and the sample time to 60 s. The active beam length was set to 2.4 mm using a lens of 300 mm. It was paid attention to get an obscuration value between 10 30％ in all measurements. The polydispers function was activated. The mathematical model 2OFD was used (according to the recommendation of Malvern Instruments).
True and tapped density DiŠerent measurements were performed: true density, poured and tapped density andˆnally Hausner Ratio was calculated. The true density was measured with a helium pycnometer AccuPyc TM 1330 (Micromeritics Instrument Corporation, Nocross, USA) with a nominal cell volume of 10 ml. As the true density is expressed as a quotient of mass and volume, the samples were weighed on balance AX204 (Mettler Toledo, Switzerland) and placed in the cell. The volume was determined by purging each sample 10 times with helium. Theˆrstˆve runs were considered as an equilibrating procedure and the average of the lastˆve measurements was taken as the value for true density.
The bulk and tap density were determined using an apparatus Type STAV 2003 (Engelsmann AG, Germany). 100 g sample was placed into a graduated cylinder. The volumes at the beginninig (bulk volume V 0 ) and after tapping 1250 times (tap volume V 1250 ) were noted. The bulk density (r b ) was calculated as a ratio of mass and initial volume V 0 , while the tapped density ( r t ) was calculated as a ratio of mass and tapped volume V 1250 . The Hausner ratio (HR) was calculated according to following equation:
HR＝r t /r b (1) HR values less than 1.25 indicate good ‰ow, whereas values greater than 1.25 indicate poor ‰ow. For values between 1.25 and 1.5 added glidant normally would improve ‰owability.
Residual moisture content The residual moisture content was determined by an infrared drying unit. Mettler Toledo Type LP 16 M (Mettler Instruments, Nanikon-ÄUster, Switzerland). Samples of approximately 1 g were prepared. They were heated up to 20 min to 110°C giving the loss of moisture in percent by weight. The approximate theoretical moisture content of the granulates was determined by the sum of the moisture contents of the diŠerent starting materials in equilibrium with 45％ relative humidity at room temperature. The experimental values of the residual moisture content of the granulates coming from a wet state after granulation in contrast to the residual moisture content of the starting materials coming from a dry state-were transformed according to Eq. 2 to values that refer to a dry state of the sample.
is the content of water referred to the dry sample, while M w is the content of water referred to the wet sample.
Flowability The ‰owability of all materials were determined with approximately 100 g of sample. By division of the mass through the ‰owing time, the fowability of diŠerent samples was calculated, Eq. 3. The measurement was carried out 5 times for each sample.
Flowability＝mass/‰owing time (3) The values of ‰owability were determined with a hopper made of plexiglass (centre angle: 37.5°, oriˆce diameter: 9 mm), which was connected to a balance (PC 8000 Mettler Toledo Gmbh, Greifensee, Switzerland). The increase in weight could be measured 375 times per minute. The data were transferred to a computer and automatically put in an excell sheet with the software Balance link (Mettler Toledo, Balance link V 3.01, Greifensee, Switzerland).
DSC analysis Melting point of diŠerent batches Design of Experiment (DOE) The purpose of this study was to investigate eŠect of formulation variables on drug release from matrix tablets which contained Carbopol71G as matrix substance. The formulations were made according to 2 3 1 fractional factorial design (FFD) where three formulation variable factors were evaluated. Formulation contained API diclofenac sodium, polymer Carbopol71G, excipient Avicel PH 101 and lubricants magnesium stearat and Aerosil . The independent variables were (levels):
The dependent variables were: Y 1  percentage of diclofenac sodium release after 30 min Y 2  percentage of diclofenac sodium release after 4 h Applying FFD 2 3 1 , three independent variables were varied on two levels; there were four formulations with diŠerent combinations of these variables. Real and coded values of evaluated factors are shown in Table 1 . The experimental design with corresponding formulations is shown in Table 2 .
Design of experiment demonstrated diŠerent eŠects of formulation factors on response variables. The results from FFD were evaluated using the following linear model.
Y＝b o ＋b 1 X 1 ＋b 2 X 2 ＋b 3 X 3 (4) Where values b 1 -b 3 represent regression coe‹-cients, Y is the response variable, and X 1 , X 2 , X 3 , represent the main eŠects of the formulation variables. Responses were: percent of diclofenac sodium released from tablets after 30 min of drug release examination (Y 1 ) and percent of diclofenac sodium released after four hours of testing (Y 2 ). In case of low or high level of polymer it was only investigated and discussed the eŠect of Carbopol71G and its speciˆc behaviour and not the presence of Avicel which in this study is in the role of excipient.
Pelletization Process According to the fractional factorial design FFD 2 3 1 , four formulations of pellets E 1 -E 4 were prepared by direct pelletization in a rotary ‰uidized bed granulator GPCG1 (Glatt, Binzen, Germany), fed with air of standardized humidity of 40±5％. In these formulations three diŠerent factors were varied on two levels (-1) and (＋1): batch of the diclofenac sodium (B, A), percentage of polymer Carbopol71G in formulation (10％, 30％) and the crushing strength of the tablet (40N, 80N) , as shown in Table 1 . Excipients were AvicelPH 101, Carbopol71G. Starting materials (excipients and 11 API) in quantity of 500 g were premixed (‰uidized) and heated in the granulator. The granulation liquidwater was sprayed onto the ‰uidized bed continuously (approximately 3 5 g/min). After spraying, the pellets were dried under smooth agitation for 4 h on the tray in the oven Hereaus RVT 360, Hanau, Germany. The process of pelletization was controlled by a computer program, process parameters are shown in Table 3 . All of the ingredients used in this study came from the same lot and the same procedure and equipment were used in the production and testing tablets.
Pellet Characterization
The pellets E 1 -E 4 were analysed on residual moisture, particle size distribution by laser diŠraction, ‰owability, true density, Hausner ratio and SEM using the same conditions and equipment as for the powder characterization. Porosity of the pellets was determined by analyzing the speciˆc surface area using the method of gas adsorption on Quantachrome Nova 2000E (Quantachrome Instruments, Florida, USA) using nitrogen gas as the adsorbate and applying the BET equation. Before performing a surface area analysis or pore size measurement, pellets were freed from possible contaminants. Surface cleaning (degassing) was carried out by placing a sample of pellets in a glass cell and heating it under a inert gas. Once degassed, the samples were brought to a constant temperature by means of an external bath, typically a dewar ‰ask containing a cryogen like liquid nitrogen. Then, small amounts of a gas (the absorbate) are admitted in steps into the evacuated sample chamber. Absorbate molecules quickly fulˆlled to the surface of every pore in the pellet sample. The process duration was 24 h. Measurements were performed in triplicate.
Compression of Pellets into Tablets
The pellets E 1 -E 4 , with added lubricants Aerosiland Magnesium stearate, were compressed into MUPS tablets on the Presster TM compaction simulator (Metropolitan Computing Corporation, East Hanover, US). The crushing strength of the tablet (-1) 40N and (＋1) 80N was controlled by adjusting the gap between the upper and lower punch in the range of 2.5 3 mm. Biconvex faced punches of 7 mm in diameter-D-tooling (with a tablet weight of 90±4,5 mg) were used and a rotary tablet press (Killian type Pharma I) was simulated at the speed of 4000 tablets per hour corresponding to a dwell time of 28.3 ms. Constant distant between punches was 7.4 mm and constant linear velocity of the compaction 0.471 m/s. Matrix tablets were examined on weight, thickness, crushing strength and diameter using Erweka TBH 30 and friability using Erweka TA 20.
Drug Release Study
The drug release of diclofenac sodium from MUPS tablets was examined using Erweka dissolution tester type DT-80. 900 ml of media were used at pH 6.8 phosphate buŠer for 8 h of examination at 37±5°C, using the USP paddle apparatus with stirring speed of 50 rpm. The concentration of diclofenac sodium was determined by UV-VIS spectrophotometric method at wavelength of 276 nm. Cumulative percentage of drug release was calculated and used in data analysis. The results are mean of three replicates.
RESULTS AND DISCUSSION
Powder Characterization
The results of the characterization of API diclofenac sodium are presented in Table 4 . Characterization demonstrated that batch A showed better physical properties, especially in particle size distribution. ＝74.04 mm, D (v, 0.9)＝291.46 mm. Results conˆrm that quality of the batch A was better and more uniform in respect of particle size distribution. Batch B is found to have coarse particles or more agglomerated comparing to batch A. DSC analysis indicated that there was no signiˆcant diŠerence in the melting points between the two batches. The values for melting point were very similar around 291 292°C during testing. SEM pictures showed diŠerent morphology n.a n.a 
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Vol. 129 (2009) of the particles of the two batches: batch A had almost round and more homogenous shape than batch B where particles were more agglomerated and with rough surfaces as shown in Fig. 1(a) and (b).
Results for both batches for the true density were similar. The calculated Hausner Ratio showed that ratio between tapped and poured density was higher at batch A. The Hausner ratio for batch A is 1.7716 which indicates very poor or even no ‰owability which is conˆrmed by ‰owability experiment. For batch B HR value (1.1110) is less but close to 1.25 and for batch B of diclofenac also is conˆrmed poor ‰owability in the ‰owability testing experiment.
Respecting this values of the physical characterization for the formulation development batch A has small advantage because of more uniform particle size distribution. The problem of poor ‰owability is resolved with added lubricant in the formulation.
Pellet Characterization
Tests demonstrated that ‰owability of the pellets E 2 and E 3 , were lower using batch B. On the other side, pellets E 1 and E 4 , containing bach A, showed higher ‰owability, especially pellet formulation E 1 which contains lower percentage of very viscous polymer ( Table 5) . Results for the speciˆc surface area showed that value is decreasing from E 1 to E 4 . Pellet formulation E 4 had high level of polymer and contained batch A with smaller particles which resulted with low porosity. Pellet formulation E 1 had low level of polymer and batch A also but the pellets were with high porosity. Formulation E 4 had uniform average particle size distribution and the greatest particle size due to a high level of polymer and his adhesive properties and at the same time the lowest result for the speciˆc surface area. True density measurements demonstrated similar results for all pellet formulations. SEM pictures showed that pellets E 1 and E 3 proper pellet, spherical shape and they consisted of smaller particles with similar size, compared to pellets E 2 and E 4 (Fig. 2) .
Tablet Characterization All four formulations were very highly compressible resulting in MUPS tablets of 40N and 80N of crushing strength, with RSD around 1％ as shown in Table 6 . It was satisfactory behaviour of the MUPS tablets concerning diŠerent percentage of the polymer in formulation. Friability of the MUPS tablets were in the limits, below 1％ after 4 min of testing. But friability results were signiˆcantly lower with MUPS tablets E 3 and E 4 . Both formulations had higher tablet crushing strength. Concerning that ‰owability of the pellets was good, pellets with added lubricants, magnesium stearat and aerosilˆlled the die ‰uently and the weight of the tablets were very uniform.
Results of the MUPS tablet characterization showed that beside of signiˆcantly diŠerent concentration of polymer in formulation experimentally designed crushing strength of tablets were reached, with corresponding tablet thickness, diameter and weight. That leads to conclusion that presence of hydrophillic polymer Carbopol71G, no matter the concentration did not in‰uence the tablet hardness. That was especially interesting after observation of the results of the dissolution study, the controlling factor for the drug release was the concentration of polymer, on the other hand in‰uence of crushing strength of MUPS tablets was less signiˆcant.
SEM shows that MUPS tablets as well as pellets had diŠerent morphology due to a diŠerent levels of polymer. Formulations of MUPS with lower concentration of polymer on the surface and on the cross section had visible spheres with regular shape MUPS E 1 and E 3 . With larger amount of polymer there is no visible shapes or spheres, only the surface which is not clearly divided MUPS E 2 and E 4 (Fig. 3) .
Compaction, however, decreased the pellet porosity and aŠected the shape of the individual pellets, resulting in more irregular pellets. Increasing the compaction pressure resulted in an increased pellet surface area and a reduced pellet thickness, which indicated that the shape was more irregular as the compaction pressure increased. As for densiˆcation of the pellets, the results imply a low reduction in porosity at the lowest compaction pressure. Thus, both the densiˆcation and the deformation of the pellets studied increased with increasing compaction pressure.
Drug Release Study Figure 4 demonstrates dissolution proˆles from MUPS tablets E 1 -E 4 . For release proˆles, similarity factor-f 2 was calculated. Value f 2 for E 1 -E 3 was 59.29, showed that these two formulations were similar. These formulations had the same lower concentration of polymer Carbopol 71, but diŠerent batch of diclofenac sodium and diŠerent crushing strength of the tablet. Value f 2 for E 2 -E 4 was 70.37, demonstrates even more similar release proˆles than E 1 -E 3 ; Formulations E 2 -E 4 had higher concentration of polymer but diŠerent batch of diclofenac sodium and diŠerent crushing strength of the tablet. Values f 2 for formulations were follow- The conclusion is that only factor X 1 , i.e., concentration of the polymer had in‰uence on the release properties of diclofenac sodium. DiŠerent batches of diclofenac sodium, consequently diŠerent structure and physical characteristics of the starting material and pellets, did not in‰uence drug release. Also diŠer-ent compressibility properties of the diŠerent formulations and resulting crushing strength of the tablet did not impact dissolution proˆles.
Results of drug release studies from formulations obtained according to FFD 2 3 1 wereˆtted into the linear model, and following models were calculated for responses: Y 1 -drug release after 0.5 h and Y 2 -drug release after 4 h of examination (Fig. 5) :
(6) At the start of the examination all the factors had negative impact on the drug release; concentration of the polymer had the greatest signiˆcance. The crushing strength of the tablet and batch of diclofenac sodium had approximated but not signiˆcant in‰uence on drug release. After 4 h of examination factor crushing strength (X 2 ) had positive impact on the drug release but not signiˆcant one. Figure 5 demonstrates that the percentage of polymer Carbopol71G (X 1 ), had the most signiˆcant in‰uence on diclofenac sodium dissolution proˆle from matrix tablets E 1 to E 4 during critical 0,5, 4 and 8 h examination, respectively. Increasing percentage of polymer resulted in decreasing release rates of the drug. The in‰uence of the diŠerent batches of diclofenac sodium (X 3 ) on dissolution E 1 -E 4 was not a signiˆcant factor. The dissolution proˆle was identical for both batches. The factor crushing strength of the tablet (X 2 ) did not have signiˆcant in‰uence on diclofenac sodium release either. That demonstrated that with hydrophilic polymer in formulation, crushing strength of the tablet did not show in‰uence on the drug release.
Decreased dissolution rates have been reported when coated pellets have been compressed without any excipient to ensure disintegration of the tablets 13, 14) and matrix tablets have also been reported to form at high compaction pressures even with the excipients included in the tablet formation. 15) The limited eŠect of the compaction pressure on the release mechanism has been attributed to deformation or fragmentation of the pellets even at low pressures. 16) Compaction of less porous coated pellets resulted in a considerably increased drug release rate, while the release rate from pellets of high porosity was scarcely aŠected by compaction.
CONCLUSION
The aim of this study was to produce pellets containing Carbopol 71G by rotary ‰uid bed granulator and then to compress them into the MUPS tablets. The in‰uence of formulation related variables were investigated aŠecting the properties of pellets subsequently compressed into MUPS and the in vitro release proˆles of diclofenac sodium from MUPS tablets.
The experiments presented in this study are result of diŠerent approach in a tablet technology and they are somewhere between a tablet as a single dosage form and MUPS as multi unit particle system. This method was applied in order to investigate a possible diŠerences in technologies of matrix systems and maybe to achieve more control of the factors over the principal response -the release of the drug. The purpose of process of pelletization and subsequently compression of the pellets into the tablets was to point all factors and parameters that have to be considered respecting the release of the drug. The main objective here was not comparation of the drug release between diŠerent dosage forms but discussion of the formulation factor impact on drug release in such a speciˆc matrix system using design of experiments. Experimental design was critically important tool in this study to improve principal response -the release of the drug. The application of experimental design techniques in formulation development reduced variability and closer conformance to target requirements, reduced development time, selection of formulation factors so that the product works well under a wide variety of conditions, so that the product is robust, determination of key formulation factor that impact formulation performance. This study could also be considered as factor screening with a relatively large region of interest because as we learn more about which factors are important and which levels produce the best results, the region of interest becomes narrower. The choice of design here involved consideration of sample size, selection of a suitable run order for the experimental trials, and determination of whether or not blocking or other randomization restrictions are involved.
Concerning the great diŠerences in applied concentrations of Carbopol71G as matrix substance, obtained values of physical characterization of pellets and MUPS were very similar. On the other hand, qualitative characterization demonstrated diŠerences in morphology of pellets and MUPS due to a diŠerent amount of polymer in formulations.
Results of drug release studies indicated that drug release rates varied between diŠerent formulations, with a range of 1 h to 8 h of dissolution. Increase of polymer resulted in decrease of percent of diclofenac sodium released after 8 h. In‰uence of crushing strength of the tablet was less signiˆcant.
The conclusion of the study is that the polymer's percentage was found to be a controlling factor in the release of diclofenac sodium from the MUPS matrix tablets. Increasing percentage of Carbopol 71G resulted in decreasing release rates of the drug. All further investigated factors had no signiˆcant in‰uence on the release proˆle of diclofenac sodium from MUPS matrix tablets. These results may assist in developing robust MUPS formulation.
